Atypical inflammatory kinase IKBKE phosphorylates and inactivates FoxA1 to promote liver tumorigenesis
Science Advances · 2024
DOI: 10.1126/sciadv.adk2285 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2024. Verfasst von Bing Gao und 13 weiteren Autor:innen. Beteiligte Einrichtung: Center of Hepato-Pancreate-Biliary Surgery, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, 510275, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Physiologically, FoxA1 plays a key role in liver differentiation and development, and pathologically exhibits an oncogenic role in prostate and breast cancers. However, its role and upstream regulation in liver tumorigenesis remain unclear. Here, we demonstrate that FoxA1 acts as a tumor suppressor in liver cancer. Using a CRISPR-based kinome screening approach, noncanonical inflammatory kinase IKBKE has been identified to inhibit FoxA1 transcriptional activity. Notably, IKBKE directly binds to and phosphorylates FoxA1 to reduce its complex formation and DNA interaction, leading to elevated hepatocellular malignancies. Nonphosphorylated mimic Foxa1 knock-in mice markedly delay liver tumorigenesis in hydrodynamic transfection murine models, while phospho-mimic Foxa1 knock-in phenocopy Foxa1 knockout mice to exhibit developmental defects and liver inflammation. Notably, Ikbke knockout delays diethylnitrosamine (DEN)-induced mouse liver tumor development. Together, our findings not only reveal FoxA1 as a bona fide substrate and negative nuclear effector of IKBKE in hepatocellular carcinioma (HCC) but also provide a promising strategy to target IKBEK for HCC therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center of Hepato-Pancreate-Biliary Surgery, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, 510275, China.
- Institute of Precision Medicine, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510275, China.
- State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong 510060, China.
- Department of Nephrology, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangdong 510060, China.
- Department of Oncology, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510275, China.
ORCID-Profile: Bing Gao, Xueji Wu, Lang Bu, Qiwei Jiang, Xiaomei Zhang, Yuanzhong Wu, Xiaoxing Li, Jingting Li, Ying Liang, Lixia Xu, Wei Xie
Zitieren
APA
Gao, B., Wu, X., Bu, L., Jiang, Q., Wang, L., Liu, H., Zhang, X., Wu, Y., Li, X., Li, J., Liang, Y., Xu, L., Xie, W., & Guo, J. (2024). Atypical inflammatory kinase IKBKE phosphorylates and inactivates FoxA1 to promote liver tumorigenesis. Science Advances. https://doi.org/10.1126/sciadv.adk2285
Vancouver
Gao B, Wu X, Bu L, Jiang Q, Wang L, Liu H, et al. Atypical inflammatory kinase IKBKE phosphorylates and inactivates FoxA1 to promote liver tumorigenesis. Science Advances. 2024. doi:10.1126/sciadv.adk2285
BibTeX
@article{Gao2024,
author = {Gao, Bing and Wu, Xueji and Bu, Lang and Jiang, Qiwei and Wang, Lei and Liu, Haining and Zhang, Xiaomei and Wu, Yuanzhong and Li, Xiaoxing and Li, Jingting and Liang, Ying and Xu, Lixia and Xie, Wei and Guo, Jianping},
title = {Atypical inflammatory kinase IKBKE phosphorylates and inactivates FoxA1 to promote liver tumorigenesis},
journal = {Science Advances},
year = {2024},
doi = {10.1126/sciadv.adk2285}
}
EUVIMED